234 related articles for article (PubMed ID: 37175872)
1. Understanding of Ovarian Cancer Cell-Derived Exosome Tropism for Future Therapeutic Applications.
Ren X; Kang C; Garcia-Contreras L; Kim D
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175872
[TBL] [Abstract][Full Text] [Related]
2. Exosomal CD47 Plays an Essential Role in Immune Evasion in Ovarian Cancer.
Shimizu A; Sawada K; Kobayashi M; Yamamoto M; Yagi T; Kinose Y; Kodama M; Hashimoto K; Kimura T
Mol Cancer Res; 2021 Sep; 19(9):1583-1595. PubMed ID: 34016744
[TBL] [Abstract][Full Text] [Related]
3. Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells.
Nakamura K; Sawada K; Kinose Y; Yoshimura A; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Morishige KI; Kurachi H; Lengyel E; Kimura T
Mol Cancer Res; 2017 Jan; 15(1):78-92. PubMed ID: 27758876
[TBL] [Abstract][Full Text] [Related]
4. Cancer cell-type tropism is one of crucial determinants for the efficient systemic delivery of cancer cell-derived exosomes to tumor tissues.
Emam SE; Abu Lila AS; Elsadek NE; Ando H; Shimizu T; Okuhira K; Ishima Y; Mahdy MA; Ghazy FS; Ishida T
Eur J Pharm Biopharm; 2019 Dec; 145():27-34. PubMed ID: 31629787
[TBL] [Abstract][Full Text] [Related]
5. Exosomes in diagnostic and therapeutic applications of ovarian cancer.
Bhavsar D; Raguraman R; Kim D; Ren X; Munshi A; Moore K; Sikavitsas V; Ramesh R
J Ovarian Res; 2024 May; 17(1):113. PubMed ID: 38796525
[TBL] [Abstract][Full Text] [Related]
6. Characterization and proteomic analysis of ovarian cancer-derived exosomes.
Liang B; Peng P; Chen S; Li L; Zhang M; Cao D; Yang J; Li H; Gui T; Li X; Shen K
J Proteomics; 2013 Mar; 80():171-82. PubMed ID: 23333927
[TBL] [Abstract][Full Text] [Related]
7. Ovarian cancer derived PKR1 positive exosomes promote angiogenesis by promoting migration and tube formation in vitro.
Zhang X; Sheng Y; Li B; Wang Q; Liu X; Han J
Cell Biochem Funct; 2021 Mar; 39(2):308-316. PubMed ID: 32876972
[TBL] [Abstract][Full Text] [Related]
8. [Effect of exosome derived from ovarian cancer cell on the differentiation of fibroblast].
Zhang D; Song KJ; Ren YZ; Sui L; Yao Q
Zhonghua Zhong Liu Za Zhi; 2022 Jul; 44(7):737-742. PubMed ID: 35880340
[No Abstract] [Full Text] [Related]
9. Regulation of exosomes released from normal ovarian epithelial cells and ovarian cancer cells.
Zhang W; Yang J; Cao D; You Y; Shen K; Peng P
Tumour Biol; 2016 Oct; ():. PubMed ID: 27714673
[TBL] [Abstract][Full Text] [Related]
10. Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200.
Kobayashi M; Salomon C; Tapia J; Illanes SE; Mitchell MD; Rice GE
J Transl Med; 2014 Jan; 12():4. PubMed ID: 24393345
[TBL] [Abstract][Full Text] [Related]
11. Microenvironmental pH is a key factor for exosome traffic in tumor cells.
Parolini I; Federici C; Raggi C; Lugini L; Palleschi S; De Milito A; Coscia C; Iessi E; Logozzi M; Molinari A; Colone M; Tatti M; Sargiacomo M; Fais S
J Biol Chem; 2009 Dec; 284(49):34211-22. PubMed ID: 19801663
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive overview of exosomes in ovarian cancer: emerging biomarkers and therapeutic strategies.
Cheng L; Wu S; Zhang K; Qing Y; Xu T
J Ovarian Res; 2017 Nov; 10(1):73. PubMed ID: 29100532
[TBL] [Abstract][Full Text] [Related]
13. Exosomes: Emerging biomarkers and targets for ovarian cancer.
Tang MK; Wong AS
Cancer Lett; 2015 Oct; 367(1):26-33. PubMed ID: 26189430
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiological Role and Potential Therapeutic Exploitation of Exosomes in Ovarian Cancer.
Shimizu A; Sawada K; Kimura T
Cells; 2020 Mar; 9(4):. PubMed ID: 32230983
[TBL] [Abstract][Full Text] [Related]
15. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T
BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333
[TBL] [Abstract][Full Text] [Related]
16. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes.
Keller S; König AK; Marmé F; Runz S; Wolterink S; Koensgen D; Mustea A; Sehouli J; Altevogt P
Cancer Lett; 2009 Jun; 278(1):73-81. PubMed ID: 19188015
[TBL] [Abstract][Full Text] [Related]
17. Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs.
Qiao L; Hu S; Huang K; Su T; Li Z; Vandergriff A; Cores J; Dinh PU; Allen T; Shen D; Liang H; Li Y; Cheng K
Theranostics; 2020; 10(8):3474-3487. PubMed ID: 32206102
[TBL] [Abstract][Full Text] [Related]
18. Graphene Oxide Enhances Biogenesis and Release of Exosomes in Human Ovarian Cancer Cells.
Gurunathan S; Kim JH
Int J Nanomedicine; 2022; 17():5697-5731. PubMed ID: 36466784
[TBL] [Abstract][Full Text] [Related]
19. Techniques Associated with Exosome Isolation for Biomarker Development: Liquid Biopsies for Ovarian Cancer Detection.
Sharma S; Salomon C
Methods Mol Biol; 2020; 2055():181-199. PubMed ID: 31502152
[TBL] [Abstract][Full Text] [Related]
20. miR-365 (microRNA): Potential Biomarker in Oral Squamous Cell Carcinoma Exosomes and Extracellular Vesicles.
Coon J; Kingsley K; Howard KM
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32727045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
